Proteasome inhibition: a new anti-inflammatory strategy
ContributorsElliott, Peter J.; Zollner, Thomas Matthias; Boehncke, Wolf-Henning
Published inJournal of molecular medicine, vol. 81, no. 4, p. 235-245
Publication date2003
Abstract
Keywords
- Acetylcysteine/*analogs & derivatives/therapeutic use
- Animals
- Anti-Inflammatory Agents/*therapeutic use
- Antineoplastic Agents/therapeutic use
- Arthritis, Rheumatoid/drug therapy
- Asthma/drug therapy
- Boronic Acids/therapeutic use
- Clinical Trials as Topic
- Cysteine Endopeptidases
- Disease Models, Animal
- Humans
- Inflammation/drug therapy
- Lysine/chemistry
- Models, Biological
- Models, Chemical
- Multienzyme Complexes/*antagonists & inhibitors
- Multiple Sclerosis/drug therapy
- NF-kappa B/metabolism
- Neoplasms/drug therapy
- Peptides/chemistry
- Protease Inhibitors/therapeutic use
- Proteasome Endopeptidase Complex
- Psoriasis/drug therapy
- Pyrazines/therapeutic use
- Reperfusion Injury
Affiliation entities Not a UNIGE publication
Citation (ISO format)
ELLIOTT, Peter J., ZOLLNER, Thomas Matthias, BOEHNCKE, Wolf-Henning. Proteasome inhibition: a new anti-inflammatory strategy. In: Journal of molecular medicine, 2003, vol. 81, n° 4, p. 235–245. doi: 10.1007/s00109-003-0422-2
Main files (1)
Article
Identifiers
- PID : unige:29849
- DOI : 10.1007/s00109-003-0422-2
- PMID : 12700891
Additional URL for this publicationhttp://link.springer.com/content/pdf/10.1007%2Fs00109-003-0422-2.pdf
Journal ISSN0946-2716